gene therapy sarepta - Search News

Order byBest matchMost fresh

Sarepta shares crash

Top News

Impacts

Sarepta shares crash as second patient dies after receiving its gene therapy

U.S. consumer prices rose slightly in May as gasoline prices remained subdued, but inflation is likely to pick up in the months as tariffs boost the cost of imported goods.

· 15h · on MSN

Sarepta Stock Plunges After Death of Second Patient Receiving Its Gene Therapy

· 6h

Ticker: Second patient death reported with gene therapy for muscular dystrophy; Salmonella poisoning linked to pistachio cream

· 10h

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.

· 1d

Sarepta reports second case of liver failure death after its gene therapy treatment

· 19h

Sarepta crashes after second death linked to Roche-partnered Elevidys

STAT12h

After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry

Another gene therapy death of a Duchenne patient has some parents and doctors criticizing the FDA's actions, even as other parents still push for the therapy.

Managed Healthcare Executive16h

Sarepta Stops Shipments of Elevidys For Non-Ambulatory DMD Patients

A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys.

20h

Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy

Sarepta suspends Elevidys use in non-ambulatory Duchenne patients after two liver failure deaths, triggering FDA review and clinical trial pause.